Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
Supporting our network's growth remains at the heart of what we do. Explore our upcoming learning opportunities and discover how you can continue to develop your skills, connect with others, and stay ahead in the sector.
________________________________________________
One Nucleus Training
*Guest blog by Romy Frow at Travel Counsellors. If you would like to submit a guest blog please email [email protected].
Business travel has always had a lot of moving parts: flights, hotels, ground transport, budgets and policies. Today, it also means navigating constantly changing geopolitics, airline schedule changes and sudden disruptions, such as the recent events and airspace restrictions in the Middle East.
LONDON, UK and COPENHAGEN, Denmark – April 22, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Oral Care AB and is pleased to announce the placement of Lucas Kromann as Chief Executive Officer (CEO) Denmark.
Healx is an AI-powered tech bio company redesigning drug discovery. With over 10,000 rare diseases affecting 400 million people globally - and 90% lacking approved treatments - our mission is to pioneer a new generation of drug discovery to bring treatments to patients faster.
We combine data, artificial intelligence and deep pharmacology expertise to develop therapies more efficiently and cost-effectively than traditional approaches.
As a long-standing partner of One Nucleus, Digital Science are committed to providing the Biotech and Pharma community with the tools needed to navigate an increasingly complex data landscape. We are excited to introduce Compass, our newest dedicated application designed to transform how your Medical Affairs and Publication Planning teams measure impact.
Genomics England is a global leader in enabling genomic medicine and research, focused on creating a world where everyone benefits from genomic healthcare. Building on the 100,000 Genomes Project, we support the NHS’s world-first national whole genome sequencing service and run the growing National Genomic Research Library, alongside delivering numerous major genomics initiatives. By connecting research and clinical care at national scale, we enable immediate healthcare benefits and advances for the future.
Job Description
At Cancer Research UK, we exist to beat cancer.
We currently have an exciting opportunity within our Drug Discovery team for an experienced individual to help lead and drive our Medicinal Chemistry strategy. We are seeking an accomplished scientific and people leader who can articulate a vision for our mission and set direction and inspire commitment for preclinical Discovery.
This role is centred on providing scientific leadership and oversight of all the technical aspects within the local Fordham immunoassay group, and throughout the wider Resolian immunoassay teams.
You will be responsible for providing supervision, guidance, and expertise, in order to facilitate the delivery of high quality methods and sample analysis results to our customers in compliance with GLP/GCP.
About RxCelerate
The RxCelerate group provides a platform for out-sourced drug discovery and development services and has a client base ranging from virtual biotech companies to multinational pharmaceutical companies. We design and deliver complete drug development programmes and project management for our clients from inception through to Phase II clinical studies.
This role will support the growth and visibility of RxCelerate and its affiliates by contributing to both business development activities and marketing and communications initiatives.